Bone sialoprotein is a specific biochemical marker of bone metabolism in postmenopausal women: A randomized 1-year study

Osteoporosis International

Volumn 11, Issue 9, 2000, Pages 790-796

  Stork S ^a   Stork C ^a   Angerer, P ^a   Kothny, W ^a   Schmitt, P ^a   Wehr, U ^a   Von Schacky, C ^a   Rambeck, W ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Biochemical bone marker; Bone sialoprotein; Hormone replacement therapy; Postmenopausal women

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; DEOXYPYRIDINOLINE; ESTRADIOL; GESTODENE; OSTEOCALCIN; PEPTIDE DERIVATIVE; PYRIDINOLINE; SIALOPROTEIN;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MINERALIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HORMONE SUBSTITUTION; HUMAN; OSTEOLYSIS; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; URINE LEVEL;

AGED; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE AND BONES; BONE RESORPTION; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; OSTEOCALCIN; POSTMENOPAUSE; PROSPECTIVE STUDIES; PYRIDINES; REFERENCE VALUES; SIALOGLYCOPROTEINS;

EID: 0033663910     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001980070058     Document Type: Article

References (25)

1. Biochemical markers for the assessment of bone turnover
2. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis
3. Prevention of early postmenopausal bone loss: Conducted 2 years study in 315 normal females
4. Reversal of postmenopausal vertebral bone loss by oestrogen and progestogen: A double blind placebo controlled study
5. 3
6. Isolation and characterization of two sialoproteins present only in bone calcified matrix
7. Regulation of bone sialoprotein mRNA by steroid hormones
8. 3 potentiate bone resorption
9. Biological variability of serum bone sialoprotein
10. Serum immunoreactive bone sialoprotein as a new marker of bone turnover in metabolic and malignant bone disease
11. Bone sialoprotein in serum of patients with malignant bone diseases
12. Improved purification of human bone sialoprotein and development of a homologous radioimmunoassay
13. Urinary pyridinium crosslinks as markers of bone resorption in osteoporosis
14. Factors affecting the assay of urinary 3-hydroxy pyridinium crosslinks of collagen as markers of bone resorption
15. Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro
16. Platelets contribute to circulating levels of bone sialoprotein in human
17. Novel serum markers of bone resorption: Clinical assessment and comparison with established urinary indices
18. Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross-links: A longitudinal and cross-sectional study
19. Short and long term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis
20. Estrogen deficiency
21. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links
22. Biochemical markers of bone turnover. II. Diagnosis, prophylaxis, and treatment of osteoporosis
23. Seasonal variation of biochemical indexes of bone turnover: Results of a population-based study
24. Response of biochemical markers of bone turnover to hormone replacement therapy: Impact of biological variability
25. Biochemical markers of bone turnover. I. Theoretical considerations and clinical use in osteoporosis